This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

LifePoint Hospitals' CEO Discusses Q1 2012 Results - Earnings Call Transcript

LifePoint Hospitals, Inc. (LPNT)

Q1 2012 Earnings Call

April 27, 2012 10:00 AM ET


William Carpenter – Chairman and CEO

Jeffrey Sherman – EVP and CFO

David Dill – President and COO


Adam Feinstein – Barclays Capital

Ralph Giacobbe – Credit Suisse

Frank Morgan – RBC Capital Markets

Gary Lieberman – Wells Fargo

AJ Rice – UBS

Kevin Fischbeck – Bank of America/Merrill Lynch

Gary Taylor – Citigroup

Thomas Gallucci – Lazard

Whit Mayo – Robert W Baird

Darren Lehrich – Deutsche Bank



Ladies and gentlemen, thank you for standing by. Welcome to the LifePoint Hospital’s First Quarter 2012 Earnings Conference Call. (Operator Instructions) On today’s call LifePoint will be making forward-looking statements based upon management’s current expectations. Numerous factors could cause LifePoint’s results to defer from these expectations and LifePoint has outlined these factors in its filings with the SEC. The company encourages you to review these filings. LifePoint also asks that you please review the cautionary language under the caption Important Legal Information in the company’s press release issued this morning.

The company undertakes no obligation to update or make any other forward-looking statements whether as a result of new information, future events or otherwise. Also please visit LifePoint’s website for links to various information and filings. (Operator Instructions) As a reminder, this conference is being recorded Friday, April 27, 2012. I would now like to turn the conference over to William Carpenter, Chairman and Chief Executive Officer. Please go ahead, sir.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,776.43 +304.06 1.85%
S&P 500 1,987.05 +35.69 1.83%
NASDAQ 4,781.2640 +73.4890 1.56%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs